Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
02/2010
02/18/2010WO2009106552A3 Contrast agents
02/18/2010US20100041905 Process for the Preparation of Substituted 2-Acetylamino-Alkoxyphenyl
02/18/2010US20100041893 Formation of tetra-substituted enamides and stereoselective reduction thereof
02/18/2010US20100041764 Therapeutic agent for diabetic neuropathy
02/18/2010US20100041763 Salicylamide derivatives as nicotinic alpha 7 modulators
02/18/2010US20100041762 Substituted fused-ring compounds for inflammation and immune-related uses
02/18/2010US20100041717 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
02/18/2010US20100041715 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof
02/18/2010US20100041657 Haloalkylsulfone substituted compounds useful for treating obesity and diabetes
02/18/2010US20100041656 Novel amide derivatives and medicinal use thereof
02/18/2010US20100040569 Photo-labile pro-fragrance conjugates
02/18/2010CA2733970A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof
02/18/2010CA2731967A1 Synthesis of cyclohexane derivatives useful as sensates in consumer products
02/17/2010EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
02/17/2010CN101648885A Amide dimer and preparation method thereof
02/16/2010USRE41135 Inhibitors of the 11-β-hydroxysteroid dehydrogenase type 1 enzyme
02/16/2010US7663000 Quinoneimines of malonic acid diamides
02/16/2010US7662999 treating gram negative bacterial infection or sepsis by neutralizing lipopolysaccharides
02/16/2010US7662995 1-(2-Fluoro-4'-trifluoromethylbiphenyl-4-yl)cyclopropanecarboxylic acid, for example; treatment and/or prevention of Alzheimer's disease; inhibiting the release of A beta 42 peptide thereby being able to modulate gamma-secretase activity without affecting other important metabolic processes
02/16/2010US7662994 Method for the preparation of crystalline dexloxiglumide and products obtained
02/16/2010US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid
02/16/2010CA2478183C Substituted amides
02/16/2010CA2385081C Carboxylic acid compound and a medicament comprising it
02/11/2010WO2010017563A1 Polymeric ionic liquids, methods of making and methods of use thereof
02/11/2010WO2010015747A1 Novel process for obtaining the crystalline form v of agomelatine
02/11/2010WO2010015746A1 Novel method for the synthesis of agomelatine
02/11/2010WO2010015745A1 Novel method for the synthesis of agomelatine
02/11/2010WO2010015744A1 Novel process for the synthesis of agomelatine
02/11/2010WO2010015655A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists
02/11/2010WO2010015415A1 Process for manufacturing adamantane derivatives with high yield
02/11/2010US20100036165 Process for obtaining the crystalline form V of agomelatine
02/11/2010US20100036163 Process for the synthesis of agomelatine
02/11/2010US20100036153 Method for Producing Substituted Diamantanes
02/11/2010US20100035999 Additives and products includings oligoesters
02/11/2010CA2732887A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists
02/10/2010EP2151430A1 New method for obtaining the crystalline form V of agomelatine
02/10/2010EP2151429A1 Process for the preparation of agomelatin
02/10/2010EP2151428A1 Process for the preparation of agomelatin
02/10/2010EP2151427A1 New method for synthesising agomelatine
02/10/2010EP2150525A1 Naphthyl(ethyl) acetamides
02/10/2010CN101646646A Novel bis(dialkylamide) compounds, process for the preparation thereof and uses thereof
02/10/2010CN101643434A New process for the synthesis of agomelatine
02/10/2010CN101643433A New process for the synthesis of agomelatine
02/10/2010CN101643432A New process for obtaining the crystalline form v of agomelatine
02/10/2010CN101643431A New process for synthesizing agomelatine
02/09/2010US7659428 Methods for producing acylphenylalanine
02/09/2010US7659351 Water- and oil-repellent fluoroacrylates
02/09/2010CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
02/09/2010CA2438704C Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
02/09/2010CA2430273C Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
02/09/2010CA2410647C Substituted phenylpropanoic acid derivatives
02/09/2010CA2294276C Branched chain fatty acids, their derivatives and use in the treatment of central nervous system disorders
02/09/2010CA2294274C Compositions and methods for reversibly increasing permeability of biomembranes
02/09/2010CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
02/04/2010WO2010014209A2 Novel fullerene cyclopropanation reaction
02/04/2010WO2010014179A1 Photolabile caged transition metal complexes and methods of using the same
02/04/2010WO2010014022A1 A process for the preparation of imatinib
02/04/2010WO2009129267A3 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
02/04/2010US20100029973 Fatty acid analogues for equilibrating bone mineral density
02/04/2010US20100029767 Anthranilic acid derivatives
02/04/2010US20100029726 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
02/04/2010US20100029705 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
02/04/2010US20100029612 2-Aminoethyl Substituted Pyrimidin-2-Ones Cyclopropanes, Pyrazolines, Pyrimidines and Benzothiazepines and Their Uses as Urotensin II and Somatostatin 5 Receptor Ligands
02/02/2010CA2555777C Dehydrating condensation agent having property of accumulating at interface with water
01/2010
01/28/2010WO2010011714A2 Reactive liquid modifiers
01/28/2010WO2010011570A1 Adamantyl diamide derivatives and uses of same
01/28/2010WO2010010174A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
01/28/2010WO2010009508A1 Antiparasitic compounds
01/28/2010WO2009132452A8 Diaryl-cyclylalkyl derivatives as calcium channel blockers
01/28/2010US20100022780 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
01/28/2010US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
01/28/2010US20100022597 2-adamantyl-butyramide derivatives as selective 11beta-hsd1 inhibitors
01/28/2010US20100022547 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections
01/28/2010US20100022546 Adamantyl diamide derivatives and uses of same
01/28/2010CA2734991A1 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
01/28/2010CA2730208A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
01/28/2010CA2728629A1 Adamantyl diamide derivatives and uses of same
01/27/2010EP2146952A1 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
01/27/2010EP1303503B1 Aniline derivatives
01/27/2010CN101636378A Malonamides as orexin antagonists
01/27/2010CN101633627A Process for producing 3-(N,N-diallyl)amino-4-p-methoxyacetanilide
01/27/2010CN100584822C Preparation of acrylic acid derivatives from alpha or beta-hydroxy carboxylic acids
01/27/2010CN100584816C Kutkin derivative, preparation method and application thereof
01/27/2010CN100584460C Catalyst for asymmetric (transfer) hydrogenation
01/26/2010US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
01/26/2010CA2310324C Method for preparing bromomethyl-biphenyl derivatives
01/21/2010WO2010009068A2 Cyclohexenyl modulators of chemokine receptor activity
01/21/2010WO2010007202A1 Enzymatic synthesis of enantiomerically enriched derivatives of cis- and trans-cyclopentane-1,2-diamines
01/21/2010WO2010006725A1 Insecticidal compounds
01/21/2010WO2009130735A4 Fatty acid derivatives for oral administration endowed with high paia- tability
01/21/2010US20100016589 Novel Anthranilic Acid Derivative as Potential Anticancer Agent and a Process for the Preparation Thereof
01/21/2010US20100016374 Compounds Which Inhibit the Glycine Transporter and Uses Thereof
01/21/2010US20100016291 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives
01/21/2010US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
01/21/2010US20100016252 Mannich Base N-Oxide Drugs
01/21/2010US20100015076 Polymer structure reacting with keratin, synthesis and use thereof
01/21/2010CA2728915A1 Benzyloxy anilide derivatives useful as potassium channel modulators
01/20/2010EP2145873A1 New compounds with activity that protects against the action of toxins and viruses in intracellular action mode
01/20/2010EP2144869A1 Improved process for working up diacetone acrylamide solutions for the preparation of pure diacetone acrylamide
01/20/2010EP1654247B1 Alkynyl aryl carboxamides
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 289